Icon
+91 94997 68112
Login Register

Caduet - (2.5mg;10,20,40mg,5mg;10,20,40,80mg; Tablet)

Atorvastatin and Amlodipine Pfizer
2.5mg;10,20,40mg,5mg;10,20,40,80mg; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
Less Than 5
Used for Hypertension (HTN) and/or angina (vasospastic or chronic stable) with dyslipidemias in patients for whom treatment with both amlodipine and atorvastatin is appropriate
Yes
******* **** *** ***-*** ***********. ****** *** ******* ******* **** **** ***** **** *******. ** *** *** ********** *****, ******* *** ****** ******* ****** (*** *** *********) ** ** ******** **** - ***** **** ******* *******. ****** *** **** ******* * ********** **** ***** (*** *** **** *********) ** *** *****, ***** *** ****** *** ******* (*** *********) ** *** **, **** ***** **** *******. **** *** ****** ****** ***** & ******* ******** *** ******* ** ********** *******. ******* ** *****'* **** ***** **** ** **** ****** '*** *** *** ************ *********. **. *****’* ******** *** ******* ** ***** **** *.*. * ****** ****** *** ** ****** **** ******. ****** *** *** *** ******** *** ******* ****** *** ********** ** ******* **** ******. ** *** **** ***** ******** *** *******. ** ***** **** ** *****’* ******** ******* ******. ****** *** ******* *** ********** **** *** *** **** ** ****** ****** *** ****** *******. ***** *** ** *** **** ** ****** ** ****. ****** ***** ** ** * ******* *********** *** **** ***** *** ******* **** ** ****** *** ******* *********.
Caduet Patent 1
******* *******
***** *******
** *****'* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** **** *, **** ******* **** ******** ** *** **,**** ** ********** *******
***** ** \ ** *** *, **** ******* ******** ******** ** *** **, ****
** *****'* ** \ ** *** **, **** ******* ******** ******** ** ***** **, ****
  1. *** *, **** : ****** ***** * **** ******* ******* ** ******** ***** ** ********.
  2. *** **, **** : ********** ********* **** *******
  3. *** **, **** : ***** ******** ****** ***** *** **** ** ****** **** *.***/****, *.***/****, *.***/****,***/****, ***/****, ***/****, ***/****, ****/****, ****/****, ****/**** ********* ** ****** *** ****** ***.
  4. *** *, **** : ****** ***** * **** ******* ***** ** ******** ***** ** ********.
  5. *** **, **** : ****** & ***** ******* * ********** ********* ** ***** ***** *** ****** ****** ** ** *** ****.
  6. *** *, **** : ***** ******** ******** & ******** *** ******* ** ********** *******
  7. *** *, **** : ******* ******** *** ******* ** ********** ******* ********* ** *** ********** *********.
  8. ***** *, **** : ** *****'* ******** ****** ***** *** **** ** **** ****** '*** (****** **, ****).
  9. ***** **, **** : ****** ***** * **** ******* ** *****'* ** ******** ***** ** ********.
  10. *** **, **** : ***** ******** ******** *** ******** *** *******.
  11. *** *, **** : ** *****'* ******** ******** *** ******** *** *******.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.